Skip to main content
PMC home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1999 Jan;52(1):1–4. doi: 10.1136/jcp.52.1.1

Genital herpes, "the new paradigm".

S Taylor 1, S Drake 1, D Pillay 1
PMCID: PMC500999  PMID: 10343604

Full text

PDF
3

Images in this article

2Image
on p.2

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ashley R. L., Militoni J., Lee F., Nahmias A., Corey L. Comparison of Western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera. J Clin Microbiol. 1988 Apr;26(4):662–667. doi: 10.1128/jcm.26.4.662-667.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ashley R. L., Wu L., Pickering J. W., Tu M. C., Schnorenberg L. Premarket evaluation of a commercial glycoprotein G-based enzyme immunoassay for herpes simplex virus type-specific antibodies. J Clin Microbiol. 1998 Jan;36(1):294–295. doi: 10.1128/jcm.36.1.294-295.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Barton S. E., Davis J. M., Moss V. W., Tyms A. S., Munday P. E. Asymptomatic shedding and subsequent transmission of genital herpes simplex virus. Genitourin Med. 1987 Apr;63(2):102–105. doi: 10.1136/sti.63.2.102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Barton S. E., Wright L. K., Link C. M., Munday P. E. Screening to detect asymptomatic shedding of herpes simplex virus (HSV) in women with recurrent genital HSV infection. Genitourin Med. 1986 Jun;62(3):181–185. doi: 10.1136/sti.62.3.181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Benedetti J., Corey L., Ashley R. Recurrence rates in genital herpes after symptomatic first-episode infection. Ann Intern Med. 1994 Dec 1;121(11):847–854. doi: 10.7326/0003-4819-121-11-199412010-00004. [DOI] [PubMed] [Google Scholar]
  6. Brock B. V., Selke S., Benedetti J., Douglas J. M., Jr, Corey L. Frequency of asymptomatic shedding of herpes simplex virus in women with genital herpes. JAMA. 1990 Jan 19;263(3):418–420. [PubMed] [Google Scholar]
  7. Brown Z. A., Selke S., Zeh J., Kopelman J., Maslow A., Ashley R. L., Watts D. H., Berry S., Herd M., Corey L. The acquisition of herpes simplex virus during pregnancy. N Engl J Med. 1997 Aug 21;337(8):509–515. doi: 10.1056/NEJM199708213370801. [DOI] [PubMed] [Google Scholar]
  8. Cowan F. M., Johnson A. M., Ashley R., Corey L., Mindel A. Antibody to herpes simplex virus type 2 as serological marker of sexual lifestyle in populations. BMJ. 1994 Nov 19;309(6965):1325–1329. doi: 10.1136/bmj.309.6965.1325. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Fleming D. T., McQuillan G. M., Johnson R. E., Nahmias A. J., Aral S. O., Lee F. K., St Louis M. E. Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med. 1997 Oct 16;337(16):1105–1111. doi: 10.1056/NEJM199710163371601. [DOI] [PubMed] [Google Scholar]
  10. Ho D. W., Field P. R., Irving W. L., Packham D. R., Cunningham A. L. Detection of immunoglobulin M antibodies to glycoprotein G-2 by western blot (immunoblot) for diagnosis of initial herpes simplex virus type 2 genital infections. J Clin Microbiol. 1993 Dec;31(12):3157–3164. doi: 10.1128/jcm.31.12.3157-3164.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Johnson R. E., Nahmias A. J., Magder L. S., Lee F. K., Brooks C. A., Snowden C. B. A seroepidemiologic survey of the prevalence of herpes simplex virus type 2 infection in the United States. N Engl J Med. 1989 Jul 6;321(1):7–12. doi: 10.1056/NEJM198907063210102. [DOI] [PubMed] [Google Scholar]
  12. Koelle D. M., Benedetti J., Langenberg A., Corey L. Asymptomatic reactivation of herpes simplex virus in women after the first episode of genital herpes. Ann Intern Med. 1992 Mar 15;116(6):433–437. doi: 10.7326/0003-4819-116-6-433. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Kudesia G., Van Hegan A., Wake S., Van Hegan R. J., Kinghorn G. R. Comparison of cell culture with an amplified enzyme immunoassay for diagnosing genital herpes simplex infection. J Clin Pathol. 1991 Sep;44(9):778–780. doi: 10.1136/jcp.44.9.778. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Lee F. K., Coleman R. M., Pereira L., Bailey P. D., Tatsuno M., Nahmias A. J. Detection of herpes simplex virus type 2-specific antibody with glycoprotein G. J Clin Microbiol. 1985 Oct;22(4):641–644. doi: 10.1128/jcm.22.4.641-644.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Lee F. K., Pereira L., Griffin C., Reid E., Nahmias A. A novel glycoprotein for detection of herpes simplex virus type 1-specific antibodies. J Virol Methods. 1986 Sep;14(2):111–118. doi: 10.1016/0166-0934(86)90041-8. [DOI] [PubMed] [Google Scholar]
  16. McLean C. S., Erturk M., Jennings R., Challanain D. N., Minson A. C., Duncan I., Boursnell M. E., Inglis S. C. Protective vaccination against primary and recurrent disease caused by herpes simplex virus (HSV) type 2 using a genetically disabled HSV-1. J Infect Dis. 1994 Nov;170(5):1100–1109. doi: 10.1093/infdis/170.5.1100. [DOI] [PubMed] [Google Scholar]
  17. Mertz G. J. Epidemiology of genital herpes infections. Infect Dis Clin North Am. 1993 Dec;7(4):825–839. [PubMed] [Google Scholar]
  18. Mertz G. J., Schmidt O., Jourden J. L., Guinan M. E., Remington M. L., Fahnlander A., Winter C., Holmes K. K., Corey L. Frequency of acquisition of first-episode genital infection with herpes simplex virus from symptomatic and asymptomatic source contacts. Sex Transm Dis. 1985 Jan-Mar;12(1):33–39. doi: 10.1097/00007435-198501000-00007. [DOI] [PubMed] [Google Scholar]
  19. Nahmias A. J., Lee F. K., Beckman-Nahmias S. Sero-epidemiological and -sociological patterns of herpes simplex virus infection in the world. Scand J Infect Dis Suppl. 1990;69:19–36. [PubMed] [Google Scholar]
  20. Slomka M. J., Ashley R. L., Cowan F. M., Cross A., Brown D. W. Monoclonal antibody blocking tests for the detection of HSV-1- and HSV-2-specific humoral responses: comparison with western blot assay. J Virol Methods. 1995 Sep;55(1):27–35. doi: 10.1016/0166-0934(95)00042-s. [DOI] [PubMed] [Google Scholar]
  21. Straus S. E., Wald A., Kost R. G., McKenzie R., Langenberg A. G., Hohman P., Lekstrom J., Cox E., Nakamura M., Sekulovich R. Immunotherapy of recurrent genital herpes with recombinant herpes simplex virus type 2 glycoproteins D and B: results of a placebo-controlled vaccine trial. J Infect Dis. 1997 Nov;176(5):1129–1134. doi: 10.1086/514103. [DOI] [PubMed] [Google Scholar]
  22. Sánchez-Martínez D., Pellett P. E. Expression of HSV-1 and HSV-2 glycoprotein G in insect cells by using a novel baculovirus expression vector. Virology. 1991 May;182(1):229–238. doi: 10.1016/0042-6822(91)90666-y. [DOI] [PubMed] [Google Scholar]
  23. Wald A., Zeh J., Selke S., Ashley R. L., Corey L. Virologic characteristics of subclinical and symptomatic genital herpes infections. N Engl J Med. 1995 Sep 21;333(12):770–775. doi: 10.1056/NEJM199509213331205. [DOI] [PubMed] [Google Scholar]
  24. Whitley R. J., Corey L., Arvin A., Lakeman F. D., Sumaya C. V., Wright P. F., Dunkle L. M., Steele R. W., Soong S. J., Nahmias A. J. Changing presentation of herpes simplex virus infection in neonates. J Infect Dis. 1988 Jul;158(1):109–116. doi: 10.1093/infdis/158.1.109. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES